Interestingly, after 21 days, the EVs‐DoxMNs group showed an increased tumour proliferation rate, whereas the CD38‐EVs‐DoxMNs group exhibited a slower tumour expansion rate (Figure 6I). Here, CD38 is linked to neoplasm.